Literature DB >> 30538603

Care of Patients Following Cure of Hepatitis C Virus Infection.

Norah A Terrault1.   

Abstract

The vast majority of persons with chronic hepatitis C virus (HCV) infection will achieve virologic cure with the current direct-acting antiviral therapies. Prevention of reinfection is an important aspect of postcure management and key to the elimination of HCV infection globally. Equally important aspects of postcure care are the prevention of liver disease progression and the management of complications in patients who have significant fibrosis at the time of achieving cure. Patients with advanced fibrosis need to remain under surveillance for liver complications, including hepatocellular carcinoma. All patients are potentially at risk for liver disease progression if other factors causing liver injury are present, such as harmful levels of alcohol use or risk factors for fatty liver including obesity, diabetes, and other metabolic comorbidities. Fatty liver is a particular threat to the long-term well-being of patients after HCV cure due to the high prevalence of its risk factors in this population. Strong counseling messages and ongoing monitoring are key.

Entities:  

Keywords:  Sustained virologic response; cirrhosis; decompensation; hepatocellular carcinoma; reinfection

Year:  2018        PMID: 30538603      PMCID: PMC6284341     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  28 in total

1.  Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.

Authors:  Nazrul Islam; Mel Krajden; Jean Shoveller; Paul Gustafson; Mark Gilbert; Jane A Buxton; Jason Wong; Mark W Tyndall; Naveed Zafar Janjua
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-12-23

2.  Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents.

Authors:  Vincenza Calvaruso; Giuseppe Cabibbo; Irene Cacciola; Salvatore Petta; Salvatore Madonia; Alessandro Bellia; Fabio Tinè; Marco Distefano; Anna Licata; Lydia Giannitrapani; Tullio Prestileo; Giovanni Mazzola; Maria Antonietta Di Rosolini; Licia Larocca; Gaetano Bertino; Antonio Digiacomo; Francesco Benanti; Luigi Guarneri; Alfonso Averna; Carmelo Iacobello; Antonio Magro; Ignazio Scalisi; Fabio Cartabellotta; Francesca Savalli; Marco Barbara; Antonio Davì; Maurizio Russello; Gaetano Scifo; Giovanni Squadrito; Calogero Cammà; Giovanni Raimondo; Antonio Craxì; Vito Di Marco
Journal:  Gastroenterology       Date:  2018-04-12       Impact factor: 22.682

Review 3.  Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.

Authors:  J M Micallef; J M Kaldor; G J Dore
Journal:  J Viral Hepat       Date:  2006-01       Impact factor: 3.728

Review 4.  Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression.

Authors:  Reem Waziry; Behzad Hajarizadeh; Jason Grebely; Janaki Amin; Matthew Law; Mark Danta; Jacob George; Gregory J Dore
Journal:  J Hepatol       Date:  2017-08-09       Impact factor: 25.083

5.  Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study.

Authors:  U Becker; A Deis; T I Sørensen; M Grønbaek; K Borch-Johnsen; C F Müller; P Schnohr; G Jensen
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

Review 6.  Management of the patient with SVR.

Authors:  Norah A Terrault; Tarek I Hassanein
Journal:  J Hepatol       Date:  2016-10       Impact factor: 25.083

7.  Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs.

Authors:  Amanda Weir; Allan McLeod; Hamish Innes; Heather Valerio; Esther J Aspinall; David J Goldberg; Stephen T Barclay; John F Dillon; Ray Fox; Andrew Fraser; Peter C Hayes; Nicholas Kennedy; Peter R Mills; Adrian J Stanley; Celia Aitken; Rory Gunson; Kate Templeton; Alison Hunt; Paul McIntyre; Sharon J Hutchinson
Journal:  Drug Alcohol Depend       Date:  2016-05-28       Impact factor: 4.492

Review 8.  Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis.

Authors:  Bryony Simmons; Jawaad Saleem; Andrew Hill; Richard D Riley; Graham S Cooke
Journal:  Clin Infect Dis       Date:  2016-01-19       Impact factor: 9.079

9.  Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies.

Authors:  Angela M Wood; Stephen Kaptoge; Adam S Butterworth; Peter Willeit; Samantha Warnakula; Thomas Bolton; Ellie Paige; Dirk S Paul; Michael Sweeting; Stephen Burgess; Steven Bell; William Astle; David Stevens; Albert Koulman; Randi M Selmer; W M Monique Verschuren; Shinichi Sato; Inger Njølstad; Mark Woodward; Veikko Salomaa; Børge G Nordestgaard; Bu B Yeap; Astrid Fletcher; Olle Melander; Lewis H Kuller; Beverley Balkau; Michael Marmot; Wolfgang Koenig; Edoardo Casiglia; Cyrus Cooper; Volker Arndt; Oscar H Franco; Patrik Wennberg; John Gallacher; Agustín Gómez de la Cámara; Henry Völzke; Christina C Dahm; Caroline E Dale; Manuela M Bergmann; Carlos J Crespo; Yvonne T van der Schouw; Rudolf Kaaks; Leon A Simons; Pagona Lagiou; Josje D Schoufour; Jolanda M A Boer; Timothy J Key; Beatriz Rodriguez; Conchi Moreno-Iribas; Karina W Davidson; James O Taylor; Carlotta Sacerdote; Robert B Wallace; J Ramon Quiros; Rosario Tumino; Dan G Blazer; Allan Linneberg; Makoto Daimon; Salvatore Panico; Barbara Howard; Guri Skeie; Timo Strandberg; Elisabete Weiderpass; Paul J Nietert; Bruce M Psaty; Daan Kromhout; Elena Salamanca-Fernandez; Stefan Kiechl; Harlan M Krumholz; Sara Grioni; Domenico Palli; José M Huerta; Jackie Price; Johan Sundström; Larraitz Arriola; Hisatomi Arima; Ruth C Travis; Demosthenes B Panagiotakos; Anna Karakatsani; Antonia Trichopoulou; Tilman Kühn; Diederick E Grobbee; Elizabeth Barrett-Connor; Natasja van Schoor; Heiner Boeing; Kim Overvad; Jussi Kauhanen; Nick Wareham; Claudia Langenberg; Nita Forouhi; Maria Wennberg; Jean-Pierre Després; Mary Cushman; Jackie A Cooper; Carlos J Rodriguez; Masaru Sakurai; Jonathan E Shaw; Matthew Knuiman; Trudy Voortman; Christa Meisinger; Anne Tjønneland; Hermann Brenner; Luigi Palmieri; Jean Dallongeville; Eric J Brunner; Gerd Assmann; Maurizio Trevisan; Richard F Gillum; Ian Ford; Naveed Sattar; Mariana Lazo; Simon G Thompson; Pietro Ferrari; David A Leon; George Davey Smith; Richard Peto; Rod Jackson; Emily Banks; Emanuele Di Angelantonio; John Danesh
Journal:  Lancet       Date:  2018-04-14       Impact factor: 202.731

10.  HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma.

Authors:  George N Ioannou; Pamela K Green; Kristin Berry
Journal:  J Hepatol       Date:  2017-09-05       Impact factor: 25.083

View more
  2 in total

Review 1.  Hepatitis C Virus in the Elderly in the Direct-Acting Antiviral Era: from Diagnosis to Cure.

Authors:  Mubeen Khan Mohammed Abdul; Heather S Snyder; Mythili Chunduru; Susan M K Lee; Sanjaya K Satapathy
Journal:  Curr Treat Options Infect Dis       Date:  2020-08-11

Review 2.  Integrated stress response in hepatitis C promotes Nrf2-related chaperone-mediated autophagy: A novel mechanism for host-microbe survival and HCC development in liver cirrhosis.

Authors:  Srikanta Dash; Yucel Aydin; Tong Wu
Journal:  Semin Cell Dev Biol       Date:  2019-08-08       Impact factor: 7.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.